Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clifton Craig Mo, M.D.

Concepts (137)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma16202451861.580 Why?
Polydeoxyribonucleotides420241361.140 Why?
Neoplasms, Second Primary1202210610.440 Why?
Metabolic Clearance Rate120133610.410 Why?
Antibodies, Monoclonal, Murine-Derived220136960.410 Why?
Myelodysplastic Syndromes1202213990.380 Why?
Anemia, Hemolytic, Autoimmune120131470.380 Why?
Melphalan220224210.330 Why?
Antigens, CD20120101990.320 Why?
Thalidomide320248860.290 Why?
Leukemia, Lymphocytic, Chronic, B-Cell2202116420.270 Why?
Paraproteinemias220222510.270 Why?
Leukemia, Myeloid, Acute1202236260.260 Why?
Dexamethasone3202419630.250 Why?
Antineoplastic Agents52024136500.230 Why?
Ikaros Transcription Factor120242330.210 Why?
Antibodies, Bispecific120232040.180 Why?
Karyopherins120211340.180 Why?
Endothelium, Vascular2202444240.180 Why?
Muscle Strength120246400.170 Why?
Antirheumatic Agents1201013790.170 Why?
Monoclonal Gammopathy of Undetermined Significance120221760.170 Why?
Hydrazines120212230.170 Why?
Cardiac Tamponade120201750.160 Why?
Oligopeptides1202411950.150 Why?
Blood Coagulation Disorders120203500.140 Why?
Immunotherapy, Adoptive2202415020.140 Why?
Receptors, Cytoplasmic and Nuclear120218570.140 Why?
Vasculitis120215260.130 Why?
Transplantation, Autologous4202421180.130 Why?
Red-Cell Aplasia, Pure12016270.130 Why?
Triazoles120219030.130 Why?
Immunotherapy3202447450.130 Why?
Pericardium120206810.120 Why?
Hematopoietic Stem Cell Transplantation3202157160.110 Why?
Treatment Failure1201926580.110 Why?
Antibodies, Monoclonal1201092450.100 Why?
Vidarabine120133370.100 Why?
Plasma Cells220165990.090 Why?
DNA, Neoplasm1201617410.090 Why?
Immunologic Factors1202015920.090 Why?
Lymphoma, B-Cell120169450.080 Why?
Humans2520247670400.080 Why?
Endothelial Cells1202135820.070 Why?
Lymphoma, Mantle-Cell120102380.070 Why?
Intestinal Pseudo-Obstruction12007490.070 Why?
Boronic Acids120109150.070 Why?
Antineoplastic Combined Chemotherapy Protocols22024118720.060 Why?
Thymoma120071860.060 Why?
Neutropenia120108920.060 Why?
Pyrazines1201012040.060 Why?
Phthalimides12024340.060 Why?
Piperidones12024370.060 Why?
Receptors, Interleukin-1712024820.060 Why?
Pandemics2202187360.060 Why?
Neoplasm, Residual2202010120.050 Why?
Immunoglobulins, Intravenous120076670.050 Why?
Resistance Training120241980.050 Why?
Neoplasm Recurrence, Local1202094100.050 Why?
Morpholines120245840.050 Why?
Idiopathic Interstitial Pneumonias12021240.050 Why?
Lymphoma1201018960.040 Why?
Viral Tropism120211020.040 Why?
Glucuronidase120212050.040 Why?
Thrombotic Microangiopathies120211240.040 Why?
Hepatic Veno-Occlusive Disease120212200.040 Why?
Aged720241713190.040 Why?
Middle Aged820242232330.040 Why?
Multiple Organ Failure120213890.040 Why?
Graft vs Host Disease2202130490.040 Why?
Thrombophilia120213080.040 Why?
Autoimmune Diseases1201022550.040 Why?
Exercise Therapy120249390.040 Why?
Quality of Life32024134850.030 Why?
Male1020243642030.030 Why?
B-Lymphocytes1201047870.030 Why?
Reticulocyte Count12016360.030 Why?
Apoptosis2202395130.030 Why?
Organ Specificity1202119660.030 Why?
Cohort Studies22022417180.030 Why?
Drug Resistance, Neoplasm1201053320.030 Why?
Reticulocytes120162870.030 Why?
Ubiquitin-Protein Ligases1202419000.030 Why?
Incidence12013215260.030 Why?
Mass Spectrometry1202222010.030 Why?
Fatigue1202215560.030 Why?
Treatment Outcome32021652950.030 Why?
Adult620242233170.030 Why?
Female820243966600.030 Why?
Adaptor Proteins, Signal Transducing1202429020.030 Why?
Heparin1202116360.030 Why?
DNA Damage1202324690.030 Why?
Bone Marrow Transplantation1202127100.030 Why?
Molecular Targeted Therapy1202428240.030 Why?
Immunoglobulins120168530.030 Why?
Stem Cell Transplantation1202115960.020 Why?
Anemia, Sickle Cell1202110650.020 Why?
Transplantation, Homologous1202148380.020 Why?
Cell Line, Tumor22023170970.020 Why?
Time Factors12013401540.020 Why?
Prognosis22022299630.020 Why?
Pilot Projects1202487320.020 Why?
Attitude to Health1202020230.020 Why?
Cross-Sectional Studies22022263250.020 Why?
Interleukin-61202132270.020 Why?
Kaplan-Meier Estimate1202165130.020 Why?
Caregivers1202223020.020 Why?
Drug Therapy, Combination1202063100.020 Why?
Disease-Free Survival1202068440.020 Why?
Interferon Regulatory Factors120102710.020 Why?
Clinical Trials as Topic1202480480.020 Why?
Combined Modality Therapy1202085350.020 Why?
T-Lymphocytes12024102540.020 Why?
Stress, Psychological1202245260.020 Why?
Lymphoma, Large B-Cell, Diffuse1201614330.020 Why?
Bone Marrow1201629260.020 Why?
Anticoagulants1202148540.020 Why?
Cell Separation1201017170.020 Why?
Prevalence12022158510.010 Why?
Proteasome Endopeptidase Complex1201013190.010 Why?
High-Throughput Nucleotide Sequencing1201636670.010 Why?
Enzyme-Linked Immunosorbent Assay1201038040.010 Why?
Genetic Testing1201635910.010 Why?
Blotting, Western1201050220.010 Why?
Depression1202282340.010 Why?
Diagnostic Imaging1201635300.010 Why?
Oligonucleotide Array Sequence Analysis1201037970.010 Why?
Young Adult22021599800.010 Why?
Diagnosis, Differential12016129860.010 Why?
Genomics1201659240.010 Why?
Prospective Studies12024548860.010 Why?
Flow Cytometry1201058910.010 Why?
Disease Progression12016136460.010 Why?
Gene Expression Profiling1201095320.010 Why?
Cell Differentiation12010116570.010 Why?
United States12021729710.010 Why?
Animals120241689650.010 Why?
Mo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (137)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.